Testing a chickenpox vaccine for children ages 1 to 12
Treatments studied
Part of Infections clinical trials.
This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 12 months and 12 years old.
- Your child must be generally healthy.
- Your child must not have had chickenpox or any chickenpox vaccine before.
- Your child must not have had close contact with someone with chickenpox in the 4 weeks before screening.
- Your child must not have a moderate or severe infection (with or without fever) at the time of vaccination.
- Your child must not have had any allergic reaction symptoms (like a rash) in the 72 hours before each vaccine dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a lower-dose varicella (chickenpox) vaccine in healthy children. It aims to see if the vaccine works and is safe. Your child may be able to join if they haven't had chickenpox or the vaccine before.
This trial tests a chickenpox vaccine in healthy children ages 1 to 12 to see how well it works and if it's safe. If your child has never had chickenpox or the vaccine, or had one dose at least 3 months ago, they may be able to join.
This trial tests a live chickenpox vaccine given at the same time as the MMR or DTaP shot for children ages 18 to 24 months. It may help protect your child from chickenpox while keeping their regular vaccine schedule on track.
This trial is testing a second dose of the chickenpox vaccine in healthy children who already received one dose. It aims to see if a booster dose provides better protection.
This study tests a combined booster vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6. It aims to see how well the vaccine boosts the immune system and if it is safe.
This study gives a second chickenpox vaccine dose to healthy children who were vaccinated once before. It mainly checks safety and measures the body’s immune response to see how well the second dose works.
Hear when a new Varicella (Chickenpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.